Yue Hao , Wei Zhao , Lulu Chang , Xingfan Chen , Chonghui Liu , Yang Liu , Lixuan Hou , Yinchun Su , Hao Xu , Yu Guo , Qixu Sun , Lili Mu , Jinghua Wang , Hulun Li , Junwei Han , Qingfei Kong
{"title":"二甲双胍通过靶向 miR-146a 抑制 AChR-specifc B 细胞和 Th17 细胞的致病功能》的更正 [Immunology Letters 250 (2022) 29-40 on Sep 13, 2022/ Manuscript ID:IMET-D-22-00159R2, PMID: 36108773]","authors":"Yue Hao , Wei Zhao , Lulu Chang , Xingfan Chen , Chonghui Liu , Yang Liu , Lixuan Hou , Yinchun Su , Hao Xu , Yu Guo , Qixu Sun , Lili Mu , Jinghua Wang , Hulun Li , Junwei Han , Qingfei Kong","doi":"10.1016/j.imlet.2024.106866","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":13413,"journal":{"name":"Immunology letters","volume":null,"pages":null},"PeriodicalIF":3.3000,"publicationDate":"2024-05-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0165247824000403/pdfft?md5=69fa9f0fc8c588c5a43291863c901948&pid=1-s2.0-S0165247824000403-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a” [Immunology Letters 250 (2022) 29–40 on Sep 13, 2022/ Manuscript ID: IMLET-D-22-00159R2, PMID: 36108773]\",\"authors\":\"Yue Hao , Wei Zhao , Lulu Chang , Xingfan Chen , Chonghui Liu , Yang Liu , Lixuan Hou , Yinchun Su , Hao Xu , Yu Guo , Qixu Sun , Lili Mu , Jinghua Wang , Hulun Li , Junwei Han , Qingfei Kong\",\"doi\":\"10.1016/j.imlet.2024.106866\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":13413,\"journal\":{\"name\":\"Immunology letters\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-05-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0165247824000403/pdfft?md5=69fa9f0fc8c588c5a43291863c901948&pid=1-s2.0-S0165247824000403-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0165247824000403\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165247824000403","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Corrigendum to “Metformin inhibits the pathogenic functions of AChR-specifc B and Th17 cells by targeting miR-146a” [Immunology Letters 250 (2022) 29–40 on Sep 13, 2022/ Manuscript ID: IMLET-D-22-00159R2, PMID: 36108773]
期刊介绍:
Immunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular and cellular immunology. The essential criteria for publication will be clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas will be considered for publication provided that they are based on solid experimental findings.
Preference will be given to papers of immediate importance to other investigators, either by their experimental data, new ideas or new methodology. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided that they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.